David Dorey
Impact in
- Infectious Diseases top 1%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
- Virology top 5%
- HIV Research and Treatment
Papers in
-
- HIV/AIDS drug development and treatment 12
- HIV/AIDS Research and Interventions 4
- Virology 1
- HIV Research and Treatment 1
- Co-authors
- Miranda I. Murray (2 shared papers)William R. Spreen (3 shared papers)David M. Margolis (2 shared papers)Sandy K Griffith (3 shared papers)Anthony Mills (2 shared papers)Johan J. Lombaard (1 shared paper)Mark S. Shaefer (1 shared paper)W. O. Wilkison (1 shared paper)
- Journals
- The Lancet (2 papers)The Journal of Infectious Diseases (1 paper)Clinical Infectious Diseases (1 paper)Diabetes Obesity and Metabolism (1 paper)New England Journal of Medicine (1 paper)
- Partner nations
- United StatesUnited KingdomBelgium
In The Last Decade
David Dorey
12 papers receiving 1.8k citations
David Dorey's Hit Papers
Peers
Comparison fields: 5 of 50
- Infectious Diseases 1.6k
- Virology 98
- Pharmaceutical Science 64
- Emergency Medicine 57
- Biomaterials 48
Countries citing papers authored by David Dorey
This map shows the geographic impact of David Dorey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Dorey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Dorey more than expected).
Fields of papers citing papers by David Dorey
This network shows the impact of papers produced by David Dorey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Dorey. The network helps show where David Dorey may publish in the future.
Co-authors
The 25 scholars most cited alongside David Dorey, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Dolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibitor-naive adults with HIV: week 48 results from the randomised, double-blind, non-inferiority SAILING study Hit paper breakdown → | 2013 | 451 |
| 2 | Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial Hit paper breakdown → | 2017 | 433 |
| 3 | 2020 | 360 | |
| 4 | 2021 | 158 | |
| 5 | 2021 | 141 | |
| 6 | Expanded Multivariable Models to Assist Patient Selection for Long-Acting Cabotegravir + Rilpivirine Treatment: Clinical Utility of a Combination of Patient, Drug Concentration, and Viral Factors Associated With Virologic Failure Hit paper breakdown → | 2023 | 102 |
| 7 | 2020 | 67 | |
| 8 | 2014 | 35 | |
| 9 | 2019 | 30 | |
| 10 | 2018 | 18 | |
| 11 | Migration-induced HIV and AIDS in rural Mozambique and Swaziland | 2010 | 9 |
| 12 | 2025 | 4 | |
| 13 | 2015 | 0 | |
| 14 | 2025 | 0 |
About David Dorey
David Dorey is a scholar working on Infectious Diseases, Virology, Emergency Medicine, Endocrinology, Diabetes and Metabolism and Economics and Econometrics, having authored 14 papers that have together received 1.8k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (12 papers), HIV/AIDS Research and Interventions (4 papers), Diabetes Treatment and Management (1 paper), Intramuscular injections and effects (1 paper), HIV/AIDS Impact and Responses (1 paper) and HIV Research and Treatment (1 paper). The work is most often cited by research in Infectious Diseases (1.6k citations), Virology (98 citations), Pharmaceutical Science (64 citations), Emergency Medicine (57 citations) and Biomaterials (48 citations). David Dorey has collaborated with scholars based in United States, United Kingdom and Belgium. Frequent co-authors include Miranda I. Murray, William R. Spreen, David M. Margolis, Sandy K Griffith, Anthony Mills, Johan J. Lombaard, Mark S. Shaefer, W. O. Wilkison, Vasiliki Chounta and Andrew P. Sykes. Their work appears in journals such as The Lancet, The Journal of Infectious Diseases, Clinical Infectious Diseases, Diabetes Obesity and Metabolism and New England Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.